Management of Vesicoureteral Reflux by Endoscopic Injection of Dextranomer/Hyaluronic Acid in Adults

Reviews in Urology

Timothy W Stark³  John M Lacy¹  David M Preston² 

[1] Department of Urology, University of Kentucky College of Medicine,, Lexington, KY;3Division of Urology, Veterans Affairs Medical Center, Cooper Drive Division,, Lexington, KY;University of Kentucky College of Medicine, and Department of Urology, University of Kentucky,, Lexington, KY

关键词: Dextranomer/hyaluronic acid;    Vesicoureteral reflux;    Pyelonephritis;   

DOI  :  

学科分类：基础医学

来源: MedReviews, LLC

【 摘 要 】

A 74-year-old man presented for evaluation after discovery of a left bladder-wall tumor. He underwent transurethral resection of bladder tumor (TURBT) operation for treatment of low-grade, Ta urothelial cancer of the bladder. The patient developed recurrent disease and returned to the operating room for repeat TURBT, circumcision, and administration of intravesical mitomycin C. The patient developed balanitis xerotica obliterans 4 years post-circumcision, requiring self-dilation with a catheter. He subsequently developed 3 consecutive episodes of left-sided pyelonephritis. Further investigation with voiding cystourethrogram (VCUG) revealed Grade 3, left-sided vesicoureteral reflux (VUR). Due to existing comorbidities, the patient elected treatment with endoscopic dextranomer/hyaluronic acid injection. A post-operative VCUG demonstrated complete resolution of left-sided VUR. This patient has remained symptom free for 8 months post-injection, with no episodes of pyelonephritis.

【 授权许可】

Unknown